Chemical Structure : HBS-101
Catalog No.: PC-24528Not For Human Use, Lab Use Only.
HBS-101 is a potent, specific midkine (MDK) inhibitor, disrupts MDK's binding to its endogenous receptors, significantly reduces cell viability of triple negative breast cancer (TNBC) (IC50 0.3-2.8 µM), clonogenic survival, invasiveness, and increased apoptosis.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
HBS-101 is a potent, specific midkine (MDK) inhibitor, disrupts MDK's binding to its endogenous receptors, significantly reduces cell viability of triple negative breast cancer (TNBC) (IC50 0.3-2.8 µM), clonogenic survival, invasiveness, and increased apoptosis.
HBS-101 exhibits distinct pharmacologic advantages, including oral bioavailability, blood-brain-barrier penetration, and in vivo stability.
The underlying mechanism of HBS-101 involves suppression of Akt/mTOR, STAT3, and NF-B pathways.
HBS-101 inhibits growth of TNBC patient-derived xenograft tumors in vivo and markedly reduced TNBC brain-metastatic-tumor growth and prolonged mice survival.
M.Wt | ||
Formula | ||
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright